Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): Buvidal, buprenorphine, Opioid-Related Disorders, Date of authorisation: 20/11/2018, Revision: 8, Status: Authorised
TO: